Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2014) 35 P405 | DOI: 10.1530/endoabs.35.P405

Tehran University of Medical Sciences, Tehran, Iran.


Aims/Introduction: To evaluate the impact of diabetes mellitus on the incidence of related micro- and macrovascular outcomes as well as cost analysis in people with type 2 diabetes mellitus.

Materials and methods: In a cohort study, registered patients with type 2 diabetes mellitus were followed for 10 years at a tertiary care center. The type of medications and clinical data were extracted from patients’ archives. Incidence of mortality, micro- and macro-vascular complications recorded in patients’ documents was analyzed. For economic evaluation, para clinic and inpatient costs were calculated.

Results: From 1562, patients with type two diabetes mellitus, a total of 1,000 patients with mean duration disease of 11.2 years, were followed. Mean cumulative incidence of diabetes-related events over 10 years were 10.9±3.5, 8.0±3.1, 4.6±1.7, 9.1±3.6 and 2.3±0.9% for neuropathy and diabetic foot, nephropathy, ophthalmic complications, cardiovascular disease and death, relatively. Average para clinic and inpatient costs per patient were 393.6±47.8 and 1520.7±104.5 USD correspondingly.

Conclusions: Our findings demonstrate high incidence and health care expenditure of type 2 diabetes-related complications among our patients. However, as the number of people with diabetes rises, so early detection and development of therapeutic strategies to decrease the incidence of type 2 diabetes mellitus complications are necessary.

Keywords: Cost of illness, incidence, type 2 diabetes

Article tools

My recent searches

No recent searches.